Genital herpesis classified as a sexually transmitted disease or infection (STI) which is caused due to herpes simplex virus. Genital herpes is diagnosed through painful blisters on and areas surrounding genitals of both men and women affecting mucus membrane which exist in the body. Genital herpes is most usual among women when compared with men. Genital herpes is a chronic condition, and presently no permanent cure has been discovered. However, medication is available to control triggered symptoms of the disease. Escalating demand for effective therapeutic options for the treatment of these infections is projected to accelerate the genital herpes treatment market during the forecasting period. In order to address the urgent requirement of better treatment for sexually transmitted infections and to fight the rapid development of antiviral-resistant species, governments around the world have taken initiatives that would support the growth of the genital herpes treatment market. Apart from that, the high expenses incurred in the treatment of genital herpes treatment are likely to hamper the market growth. As a result, the genital herpes treatment market is anticipated to grow at the rate of 4.1% CAGR by 2027.

View Complete Report: @https://www.infoholicresearch.com/report/genital-herpes-treatment-market/

Genital Herpes Treatment Market based on Type of Drugs
Acyclovir
Famciclovir
Valacyclovir
Others
Genital Herpes Treatment Market based on Distribution channels
Hospital Pharmacies
Retail Pharmacies
Drug stores
Online Pharmacies
Genital Herpes Treatment Market based on Route of Administration
Oral
Topical
Genital Herpes Treatment Market based on Geography
North America
Europe
Asia Pacific
Rest of the World
On the basis of types of drugs, the genital herpes treatment market is majorly divided into Acyclovir, Famciclovir, Valacyclovir, and Others. The acyclovir drug type is projected to have a significant share in the market. The acyclovir drugs are considered very effective in suppressing the frequency and quantity of the genital herpes simplex virus. Acyclovir decreases the pain and speeds the healing of sores or blisters in people who had first-time or repeat outbreaks of genital herpes. It works by preventing the spread of the herpes virus in the body. Thus, the above-mentioned advantages of the acyclovir drug are boosting segment growth.

Request a Sample of this Report: @https://www.infoholicresearch.com/request-a-sample-report/?repid=14747



Contact Us:
Marketing Team
Infoholic Research LLP
[email protected]
[email protected]